mPharma Venture

The new funding, the value of which was not disclosed, comes at a pivotal moment for the company. It follows a significant leadership transition, with Kwesi Arhin taking over as CEO. This investment signals a strong vote of confidence from BII, a long-term backer, in the new leadership’s vision for regional expansion. The capital is earmarked to strengthen mPharma’s operations in Ghana and, most notably, to finance its expansion into Francophone West Africa, with an immediate focus on Togo and Benin.